Physician profile
Reza Mobarak
NPI 1013962539
$3,277.84
in general payments reported to CMS, 2019-2025
48 companies · $760 in 2025
The $760 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $535 · 2020: $195 · 2021: $276 · 2022: $310 · 2023: $444 · 2024: $758 · 2025: $760.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,962.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,961.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $402.41 | 2022-2024 | Senza |
| Paratek Pharmaceuticals, INC. | $332.88 | 2021-2025 | Nuzyra |
| Smith+Nephew, INC. | $264.34 | 2019-2025 | Collagenase Santyl, Hat-Trick, Renasys Touch |
| Kerecis Limited | $196.90 | 2020-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Orthofix Medical, INC. | $195.50 | 2021-2025 | Physio-Stim |
| Horizon Therapeutics Plc | $150.04 | 2019-2021 | |
| Globus Medical, INC. | $144.33 | 2025 | Senza |
| Cashflow Solutions, LLC | $99.95 | 2022-2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Wright Medical Technology, INC. | $86.26 | 2019-2020 | |
| Bioventus LLC | $81.53 | 2025 | Exogen Ultrasound Bone Healing System |
| Stryker Corporation | $79.82 | 2019-2021 | |
| Depuy Synthes Sales INC. | $79.10 | 2024-2025 | Motoband, Minibunion |
| Tactile Systems Technology INC | $78.58 | 2019-2021 | |
| Bone Support INC. | $70.23 | 2019 | |
| Organogenesis INC. | $69.90 | 2019-2023 | Puraply |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $59.84 | 2024 | Intellis Adaptivestim |
| Melinta Therapeutics, LLC | $59.78 | 2019-2022 | |
| Convatec INC. | $46.06 | 2019-2025 | |
| Abbott Laboratories | $44.23 | 2021-2023 | Proclaim |
| Nabriva Therapeutics, Plc | $40.37 | 2020-2021 | |
| Advanced Oxygen Therapy INC. | $40.30 | 2020-2023 | Topical Oxygen Chamber For Extremities |
| Baxter Healthcare | $38.55 | 2024 | Perclot |
| Reddress USA, INC. | $37.52 | 2025 | Actigraft |
| Trilliant Surgical LLC. | $37.22 | 2019 | |
| Treace Medical Concepts, INC. | $36.94 | 2025 | |
| Teleflex LLC | $36.72 | 2025 | Quikclot |
| Pacira Pharmaceuticals Incorporated | $35.13 | 2019-2020 | |
| Biocomposites INC | $30.71 | 2025 | Stimulan |
| Reprise Biomedical, INC. | $30.30 | 2024-2025 | Miro3d |
| Acell, INC. | $26.67 | 2019 | |
| Next Science LLC | $26.27 | 2023 | Surgx, Xperience, Blastx |
| Ets Wound Care LLC | $25.91 | 2023 | |
| Biowound Solutions, INC. | $25.36 | 2025 | Bio-Connekt |
| Kci USA, INC. | $24.86 | 2023 | Activ.A.C. |
| Innovation Technologies INC | $23.89 | 2024 | Irrisept |
| Grt US Holding, INC. | $21.89 | 2021 | |
| Abbvie INC. | $21.66 | 2023 | |
| Trimed, INC. | $21.44 | 2024 | |
| Pylant Medical | $18.54 | 2025 | |
| Amgen INC. | $18.22 | 2025 | Krystexxa |
| Ermi LLC | $18.03 | 2019 | |
| Medline Industries LP | $16.54 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $16.53 | 2022 | |
| Allergan, INC. | $15.92 | 2019 | |
| Zimmer Biomet Holdings, INC. | $14.59 | 2019 | |
| Aroa Biosurgery Incorporated | $12.74 | 2020 | |
| Djo, LLC | $12.47 | 2019 | |
| Arteriocyte Medical Systems, INC. | $10.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reza Mobarak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.